Cargando…

Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases

OBJECTIVE: Adverse drug reactions (ADRs) are one of the major causes of mortality. One of the major causes of ADR is drug–drug interactions. The purpose of this study was to evaluate the prevalence and characteristics of ADRs caused by the drug interactions in the nephrology departments. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahraki, Tahereh Gholipur, Yari, Fatemeh, Seirafian, Shiva, Badri, Shirinsadat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547740/
https://www.ncbi.nlm.nih.gov/pubmed/33102388
http://dx.doi.org/10.4103/jrpp.JRPP_20_38
_version_ 1783592482918891520
author Shahraki, Tahereh Gholipur
Yari, Fatemeh
Seirafian, Shiva
Badri, Shirinsadat
author_facet Shahraki, Tahereh Gholipur
Yari, Fatemeh
Seirafian, Shiva
Badri, Shirinsadat
author_sort Shahraki, Tahereh Gholipur
collection PubMed
description OBJECTIVE: Adverse drug reactions (ADRs) are one of the major causes of mortality. One of the major causes of ADR is drug–drug interactions. The purpose of this study was to evaluate the prevalence and characteristics of ADRs caused by the drug interactions in the nephrology departments. METHODS: This cross-sectional prospective study was carried out in the nephrology department on 117 patients who received at least two medicines. Drug interactions were determined, and the patients were evaluated for the presence of a drug complication. FINDINGS: A total of fifty ADRs were observed in 39 patients, whereas 26% of total ADRs (13 drug complications) were due to drug interactions. About 69% and 31% of complications were classified in terms of severity, in the category of “severe” and “moderate” complications, respectively. Warfarin had the highest contribution to major interactions (33.33%). CONCLUSION: ADRs, which specially occurred due to drug interactions, are particularly important for patients taking multiple medications (e.g., patient with renal insufficiency). Therefore, special attention should be paid to preventing and reducing ADRs in these patients' population.
format Online
Article
Text
id pubmed-7547740
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-75477402020-10-22 Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases Shahraki, Tahereh Gholipur Yari, Fatemeh Seirafian, Shiva Badri, Shirinsadat J Res Pharm Pract Brief Communication OBJECTIVE: Adverse drug reactions (ADRs) are one of the major causes of mortality. One of the major causes of ADR is drug–drug interactions. The purpose of this study was to evaluate the prevalence and characteristics of ADRs caused by the drug interactions in the nephrology departments. METHODS: This cross-sectional prospective study was carried out in the nephrology department on 117 patients who received at least two medicines. Drug interactions were determined, and the patients were evaluated for the presence of a drug complication. FINDINGS: A total of fifty ADRs were observed in 39 patients, whereas 26% of total ADRs (13 drug complications) were due to drug interactions. About 69% and 31% of complications were classified in terms of severity, in the category of “severe” and “moderate” complications, respectively. Warfarin had the highest contribution to major interactions (33.33%). CONCLUSION: ADRs, which specially occurred due to drug interactions, are particularly important for patients taking multiple medications (e.g., patient with renal insufficiency). Therefore, special attention should be paid to preventing and reducing ADRs in these patients' population. Wolters Kluwer - Medknow 2020-06-26 /pmc/articles/PMC7547740/ /pubmed/33102388 http://dx.doi.org/10.4103/jrpp.JRPP_20_38 Text en Copyright: © 2020 Journal of Research in Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Brief Communication
Shahraki, Tahereh Gholipur
Yari, Fatemeh
Seirafian, Shiva
Badri, Shirinsadat
Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases
title Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases
title_full Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases
title_fullStr Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases
title_full_unstemmed Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases
title_short Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases
title_sort potential of drug interactions as a cause of adverse drug reactions in patients with kidney diseases
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547740/
https://www.ncbi.nlm.nih.gov/pubmed/33102388
http://dx.doi.org/10.4103/jrpp.JRPP_20_38
work_keys_str_mv AT shahrakitaherehgholipur potentialofdruginteractionsasacauseofadversedrugreactionsinpatientswithkidneydiseases
AT yarifatemeh potentialofdruginteractionsasacauseofadversedrugreactionsinpatientswithkidneydiseases
AT seirafianshiva potentialofdruginteractionsasacauseofadversedrugreactionsinpatientswithkidneydiseases
AT badrishirinsadat potentialofdruginteractionsasacauseofadversedrugreactionsinpatientswithkidneydiseases